Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Pavel

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
The Journal of Allergy and Clinical Immunology|February 10, 2019
GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitisEmma Guttman-Yassky, Ana B Pavel, Lisa Zhou, et al.
The Journal of Allergy and Clinical Immunology|January 28, 2019
Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitisLisa Zhou, Alexandra Leonard, Ana B Pavel, et al.
Scientific Reports|August 11, 2023
Integrative genetic and genomic networks identify microRNA associated with COPD and ILDAna B Pavel, Carly Garrison, Lingqi Luo, et al.
Allergy|April 18, 2021
Vascular inflammation in moderate-to-severe atopic dermatitis is associated with enhanced Th2 responseAxel P Villani, Ana B Pavel, Jianni Wu, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 4, 2018
Distinct transcriptomic profiles of early-onset atopic dermatitis in blood and skin of pediatric patientsPatrick M Brunner, Ariel Israel, Alexandra Leonard, et al.
Journal of the American Academy of Dermatology|May 27, 2021
Scalp and serum profiling of frontal fibrosing alopecia reveals scalp immune and fibrosis dysregulation with no systemic involvementCelina Dubin, Jacob W Glickman, Ester Del Duca, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 11, 2021
Immune and barrier characterization of atopic dermatitis skin phenotype in Tanzanian patientsClaudia C V Lang, Yael Renert-Yuval, Ester Del Duca, et al.
Journal of the American Academy of Dermatology|January 22, 2018
Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trialEmma Guttman-Yassky, Patrick M Brunner, Avidan U Neumann, et al.
The Journal of Allergy and Clinical Immunology|August 20, 2018
Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumabPatrick M Brunner, Ana B Pavel, Saakshi Khattri, et al.
The Journal of Allergy and Clinical Immunology|April 23, 2021
Mapping atopic dermatitis and anti-IL-22 response signatures to type 2-low severe neutrophilic asthmaYusef Eamon Badi, Ana B Pavel, Stelios Pavlidis, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
The Journal of Allergy and Clinical Immunology|February 10, 2019
GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitisEmma Guttman-Yassky, Ana B Pavel, Lisa Zhou, et al.
The Journal of Allergy and Clinical Immunology|January 28, 2019
Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitisLisa Zhou, Alexandra Leonard, Ana B Pavel, et al.
Scientific Reports|August 11, 2023
Integrative genetic and genomic networks identify microRNA associated with COPD and ILDAna B Pavel, Carly Garrison, Lingqi Luo, et al.
Allergy|April 18, 2021
Vascular inflammation in moderate-to-severe atopic dermatitis is associated with enhanced Th2 responseAxel P Villani, Ana B Pavel, Jianni Wu, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 4, 2018
Distinct transcriptomic profiles of early-onset atopic dermatitis in blood and skin of pediatric patientsPatrick M Brunner, Ariel Israel, Alexandra Leonard, et al.
Journal of the American Academy of Dermatology|May 27, 2021
Scalp and serum profiling of frontal fibrosing alopecia reveals scalp immune and fibrosis dysregulation with no systemic involvementCelina Dubin, Jacob W Glickman, Ester Del Duca, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 11, 2021
Immune and barrier characterization of atopic dermatitis skin phenotype in Tanzanian patientsClaudia C V Lang, Yael Renert-Yuval, Ester Del Duca, et al.
Journal of the American Academy of Dermatology|January 22, 2018
Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trialEmma Guttman-Yassky, Patrick M Brunner, Avidan U Neumann, et al.
The Journal of Allergy and Clinical Immunology|August 20, 2018
Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumabPatrick M Brunner, Ana B Pavel, Saakshi Khattri, et al.
The Journal of Allergy and Clinical Immunology|April 23, 2021
Mapping atopic dermatitis and anti-IL-22 response signatures to type 2-low severe neutrophilic asthmaYusef Eamon Badi, Ana B Pavel, Stelios Pavlidis, et al.
Pageof 8